The new IRP itself becomes operational in six weeks’ time, on 1 January 2024.
Applications for new medicines via the MHRA’s forthcoming International Recognition procedure (IRP) move a step closer today, with the launch of the Agency’s new online ‘Eligibility Checker’ tool.įrom today (Monday 20 November), applicants should use this new tool to determine whether their Marketing Authorisation Application (MAA) is suitable for IRP and to identify which route (A or B) to follow, before submitting an IRP application.
